Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 9.93 is 102% above its 3-year average of 4.91, near the high end of its 3-year range (0.00–11.94).
As of the fiscal period ended Tuesday, June 30, 2026. 29.45% above its 12-month average of 7.67.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 9.93.
QUICK RATIO (ACID-TEST)
9.93
QUICK RATIO (ACID-TEST) AVG TTM
7.67
QUICK RATIO (ACID-TEST) AVG 3Y
5.19
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+29.45%
CURRENT VS 3Y AVG
+91.49%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+196.52%
vs the sector median at left
Zenas BioPharma, Inc.
Market Cap
$1.69B
Quick Ratio (Acid-Test)
9.93
TTM Avg
7.67
3Y Avg
5.19
5Y Avg
N/A
Market Cap
$1.70B
Quick Ratio (Acid-Test)
5.08
TTM Avg
6.50
3Y Avg
5.46
5Y Avg
6.20
Market Cap
$1.70B
Quick Ratio (Acid-Test)
1.07
TTM Avg
0.89
3Y Avg
0.95
5Y Avg
0.97
Market Cap
$1.72B
Quick Ratio (Acid-Test)
6.65
TTM Avg
5.42
3Y Avg
7.28
5Y Avg
7.47
Market Cap
$1.73B
Quick Ratio (Acid-Test)
1.02
TTM Avg
1.38
3Y Avg
1.55
5Y Avg
2.14
Market Cap
$1.74B
Quick Ratio (Acid-Test)
1.70
TTM Avg
1.79
3Y Avg
1.95
5Y Avg
2.14
Market Cap
$1.74B
Quick Ratio (Acid-Test)
1.78
TTM Avg
1.68
3Y Avg
1.66
5Y Avg
1.61
Market Cap
$1.63B
Quick Ratio (Acid-Test)
1.07
TTM Avg
1.43
3Y Avg
1.49
5Y Avg
1.78
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zenas BioPharma, Inc. (ZBIO) | $1.69B | 9.93 | 7.67 | 5.19 | N/A |
| Personalis, Inc. (PSNL)vs › | $1.70B | 5.08 | 6.50 | 5.46 | 6.20 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.70B | 1.07 | 0.89 | 0.95 | 0.97 |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.72B | 6.65 | 5.42 | 7.28 | 7.47 |
| Xeris Biopharma Holdings, Inc. (XERS)vs › | $1.73B | 1.02 | 1.38 | 1.55 | 2.14 |
| Novocure Ltd (NVCR)vs › | $1.74B | 2.70 | 2.06 | 4.13 | 5.41 |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.74B | 1.70 | 1.79 | 1.95 | 2.14 |
| Surgery Partners, Inc. (SGRY)vs › | $1.74B | 1.78 | 1.68 | 1.66 | 1.61 |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.63B | 1.07 | 1.43 | 1.49 | 1.78 |
| Absci Corporation (ABSI)vs › | $1.76B | 10.63 | 5.62 | 5.25 | 6.00 |
Quick Ratio
9.93
Excludes inventory
Current Ratio
9.93
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 9.93 |
| 2026-03-31 | 11.94 |
| 2025-12-31 | 5.61 |
| 2025-09-30 | 5.66 |
| 2025-06-30 | 5.23 |
| 2025-03-31 | 6.47 |
| 2024-12-31 | 6.21 |
| 2024-09-30 | 8.95 |
| 2024-06-30 | 4.82 |
| 2024-03-31 | 1.31 |
| 2023-12-31 | 2.57 |
| 2023-09-30 | 4.93 |
| 2023-06-30 | 0.00 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 0.00 |
